Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis
J. Canto-Gomes, D. Boleixa, C. Teixeira, A. Martins da Silva, I. Gonzalez-Suarez, J. J. Cerqueira, M. Correia-Neves, C. Nobrega
This study compares the effects of different disease-modifying therapies on immune cell profiles in relapsing-remitting multiple sclerosis patients, finding varied impacts on T, B, and NK cells.
bioRxiv · Jul 20, 2023Immunology